DK3099298T3 - Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner - Google Patents
Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner Download PDFInfo
- Publication number
- DK3099298T3 DK3099298T3 DK15704827.3T DK15704827T DK3099298T3 DK 3099298 T3 DK3099298 T3 DK 3099298T3 DK 15704827 T DK15704827 T DK 15704827T DK 3099298 T3 DK3099298 T3 DK 3099298T3
- Authority
- DK
- Denmark
- Prior art keywords
- microbible
- zidovudin
- infections
- treatment
- combination therapies
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1401617.4A GB201401617D0 (en) | 2014-01-30 | 2014-01-30 | Novel combination and use |
| PCT/GB2015/050209 WO2015114340A1 (en) | 2014-01-30 | 2015-01-29 | Zidovudine combination therapies for treating microbial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3099298T3 true DK3099298T3 (da) | 2019-05-27 |
Family
ID=50344128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15704827.3T DK3099298T3 (da) | 2014-01-30 | 2015-01-29 | Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10098904B2 (da) |
| EP (1) | EP3099298B8 (da) |
| JP (1) | JP6633529B2 (da) |
| CN (1) | CN106170286B (da) |
| CA (1) | CA2936714A1 (da) |
| DK (1) | DK3099298T3 (da) |
| ES (1) | ES2719557T3 (da) |
| GB (1) | GB201401617D0 (da) |
| HR (1) | HRP20190637T1 (da) |
| HU (1) | HUE043702T2 (da) |
| PL (1) | PL3099298T3 (da) |
| PT (1) | PT3099298T (da) |
| SI (1) | SI3099298T1 (da) |
| WO (1) | WO2015114340A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201305277D0 (en) * | 2013-03-22 | 2013-05-01 | Helperby Therapeutics Ltd | Novel combination and use |
| JP6854752B2 (ja) * | 2014-07-30 | 2021-04-07 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｈｄｌ上昇剤又はｈｄｌ模倣剤を用いた治療に対する応答性を予測するための遺伝マーカー |
| GB201521771D0 (en) * | 2015-12-10 | 2016-01-27 | Helperby Therapeutics Ltd | Formulation |
| BR112018016517B1 (pt) | 2016-02-12 | 2024-03-12 | Cipla Limited | Composições farmacêuticas incluindo uma droga antirretroviral e um intensificador farmacocinético, métodos operacionais das composições e kit com antirretroviral e intensificador |
| GB201610869D0 (en) * | 2016-06-22 | 2016-08-03 | Helperby Therapeutics Ltd | Combination |
| GB201612093D0 (en) * | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
| GB201704620D0 (en) * | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
| KR102118198B1 (ko) * | 2018-02-28 | 2020-06-02 | 주식회사 엠디헬스케어 | 리조비움 속 세균 유래 나노소포 및 이의 용도 |
| GB201807046D0 (en) * | 2018-04-30 | 2018-06-13 | Helperby Therapeutics Ltd | Combination |
| GB201910787D0 (en) * | 2019-07-29 | 2019-09-11 | Helperby Therapeutics Ltd | Pharmaceutical development |
| GB201913068D0 (en) | 2019-09-10 | 2019-10-23 | Helperby Therapeutics Ltd | Combination |
| GB201914847D0 (en) | 2019-10-14 | 2019-11-27 | Helperby Therapeutics Ltd | Combination |
| CN114196586B (zh) * | 2021-12-20 | 2023-04-11 | 郑州大学 | 一株蒙氏肠球菌及其在发酵中草药中的应用 |
| CN117243966A (zh) * | 2022-06-10 | 2023-12-19 | 香港城市大学 | 一种治疗耐碳青霉烯肺炎克雷伯氏菌感染的组合物 |
| GB202213753D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial combinations |
| GB202213750D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial |
| GB202314387D0 (en) | 2023-09-20 | 2023-11-01 | Helperby Therapeutics Ltd | Antimicrobial combinations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA39896C2 (uk) | 1993-10-22 | 2001-07-16 | Смітклайн Бічам Корпорейшн | Фармацевтична або ветеринарна композиція мупіроцину та спосіб її приготування |
| PT1129212E (pt) | 1998-11-09 | 2004-11-30 | Helperby Therapeutics Ltd | Processo de triagem para agentes antibacterianos |
| US6974585B2 (en) | 2001-08-01 | 2005-12-13 | Medlogic Global Limited | Durable multi-component antibiotic formulation for topical use |
| AU2003209674A1 (en) * | 2002-03-12 | 2003-09-22 | Council Of Scientific And Industrial Research | Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| JP2003310752A (ja) * | 2002-04-25 | 2003-11-05 | Toray Ind Inc | 生理活性物質固定化成型品の製造方法 |
| JP2007501809A (ja) | 2003-08-08 | 2007-02-01 | ユリシーズ・ファーマシューティカル・プロダクツ・インコーポレイテッド | 抗菌剤としてのハロゲン化キナゾリニルニトロフラン |
| KR20070091613A (ko) | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물 |
| ES2279707B1 (es) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | Formulaciones orales que comprenden 3'-azidonucleosidos. |
-
2014
- 2014-01-30 GB GBGB1401617.4A patent/GB201401617D0/en not_active Ceased
-
2015
- 2015-01-29 PT PT15704827T patent/PT3099298T/pt unknown
- 2015-01-29 HR HRP20190637TT patent/HRP20190637T1/hr unknown
- 2015-01-29 CA CA2936714A patent/CA2936714A1/en not_active Abandoned
- 2015-01-29 ES ES15704827T patent/ES2719557T3/es active Active
- 2015-01-29 CN CN201580006601.6A patent/CN106170286B/zh not_active Expired - Fee Related
- 2015-01-29 EP EP15704827.3A patent/EP3099298B8/en not_active Not-in-force
- 2015-01-29 US US15/111,275 patent/US10098904B2/en not_active Expired - Fee Related
- 2015-01-29 JP JP2016549373A patent/JP6633529B2/ja not_active Expired - Fee Related
- 2015-01-29 DK DK15704827.3T patent/DK3099298T3/da active
- 2015-01-29 WO PCT/GB2015/050209 patent/WO2015114340A1/en not_active Ceased
- 2015-01-29 SI SI201530684T patent/SI3099298T1/sl unknown
- 2015-01-29 HU HUE15704827A patent/HUE043702T2/hu unknown
- 2015-01-29 PL PL15704827T patent/PL3099298T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6633529B2 (ja) | 2020-01-22 |
| US20160331773A1 (en) | 2016-11-17 |
| EP3099298B8 (en) | 2019-05-22 |
| CN106170286B (zh) | 2019-07-23 |
| CA2936714A1 (en) | 2015-08-06 |
| PL3099298T3 (pl) | 2019-10-31 |
| EP3099298A1 (en) | 2016-12-07 |
| HUE043702T2 (hu) | 2019-09-30 |
| ES2719557T3 (es) | 2019-07-11 |
| JP2017504647A (ja) | 2017-02-09 |
| SI3099298T1 (sl) | 2019-09-30 |
| PT3099298T (pt) | 2019-05-27 |
| EP3099298B1 (en) | 2019-03-20 |
| HRP20190637T1 (hr) | 2019-10-04 |
| HK1231389A1 (en) | 2017-12-22 |
| US10098904B2 (en) | 2018-10-16 |
| GB201401617D0 (en) | 2014-03-19 |
| WO2015114340A1 (en) | 2015-08-06 |
| CN106170286A (zh) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3099298T3 (da) | Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner | |
| DK3134530T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3125875T3 (da) | Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande | |
| HRP20181130T1 (hr) | Postupci za liječenje infekcija virusom filoviridae | |
| DK3785717T3 (da) | Fremgangsmåder til behandling af coronaviridae-infektioner | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3466432T3 (da) | Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner | |
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3492632T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK3117310T3 (da) | Håndtering af behandling associeret med valgte arkitektoniske indretninger | |
| DK3180087T3 (da) | Kombinationsterapier med anti cd40-antistoffer | |
| DK3166976T3 (da) | Anti-pd-l1-kombinationer til behandling af tumorer | |
| DK3718507T3 (da) | Anordninger til behandling af nedre ekstremitetsvaskulatur | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK2964315T3 (da) | System til behandling af neuromotorisk dysfunktion | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3265087T3 (da) | Fremgangsmåde til behandling med tradipitant | |
| BR112016022976A2 (pt) | Métodos para o tratamento de hcv | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| DK3164394T3 (da) | Gls1-inhibitorer til behandling af sygdomme | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| HRP20181572T1 (hr) | Režim doziranja spoja fgf-18 |